Drug intelligence / Profile preview

placenta polypeptide injection

Development stage
Unknown
Lead developer
Peking Union Medical College Hospital
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Intramuscular, Intravenous
01

Overview

Placenta polypeptide injection is a biologic therapeutic derived from human placental tissue, containing a complex mixture of low-molecular-weight peptides, amino acids, and nucleic acid components. It is widely utilized in China as an immunomodulator and anti-inflammatory agent. The drug is indicated for the adjunctive treatment of various conditions, including immune deficiencies, chronic inflammatory diseases, and as a supportive therapy for cancer patients to mitigate the side effects of chemotherapy and radiotherapy. In the context of dermatology, it is being investigated for its ability to treat moderate to severe sensitive skin by inhibiting inflammatory responses and promoting skin barrier repair, as evidenced by clinical trials conducted at institutions like Peking Union Medical College Hospital.

Brand names
Tai Pan Duo Tai
Other names
human placenta polypeptideplacenta polypeptide

Beyond the preview

Go deeper on placenta polypeptide injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on placenta polypeptide injection.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call